Clinical Trial Update: OptiGon - Optimising Laboratory Assays for Immune Responses to Gonococcus

View source ↗

Summary

A completed clinical trial evaluating Optimising Laboratory Assays for Immune Responses to Gonococcus (OptiGon) for gonorrhea. The update provides status only, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gonorrhea

Snippet

Sponsor: University of Oxford | Conditions: Gonorrhea | Status: COMPLETED